Company intelligence / Profile preview
Genexine
South Koreagenexine.com ↗
- Ownership
- Private
- Employees
- ~76
- Development stage
- Other
01
Overview
Genexine has multiple innovative biologic candidates in late-stage clinical development. Lead programs include GX-H9 for growth hormone deficiency and GX-E4 for CKD-induced anemia—both in Phase 3. Its immunotherapy candidate GX-I7 is being studied for multiple cancers. The company’s platforms enable long half-life drugs and novel immunotherapies. Recent merger with EPD Biotherapeutics adds targeted protein degradation capabilities to its pipeline[2][3][4].
- Therapeutic areas
- OncologyImmunologyRare Diseases
- Modalities
- Long-acting biologicsDNA vaccinesAntibody fusion proteinsImmunotherapeutics[2][3][4][5]
- Industry
- Biotech
02
Drug pipeline
16 assets15 more assets in the full pipeline.
03
Partnerships
Global partnerships with pharmaceutical companies for co-development and commercialization of lead assets; specific partners not named in provided results but referenced as “multiple partnerships” globally.[2][3]
Beyond the preview
Go deeper on Genexine.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genexine.